Oliver Williams

Oliver Williams is a Junior Bioinformatician at Neogene Therapeutics since December 2022, with prior experience as a Bioinformatics intern at Frame Cancer Therapeutics from September 2021 to May 2022, and as a Systems Biology and Bioinformatics intern at Leiden University/LACDR/Division of Biopharmaceutics from October 2020 to June 2021, where a pipeline was developed to integrate minimum inhibitory concentration and whole genome sequence data for studying antibiotic collateral sensitivity. Educational qualifications include a Master of Science in Systems Biology from the University of Amsterdam (2019-2021) and a Bachelor of Science (Hons) in Pharmacology from the University of Bristol (2012-2015).